This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management of hyponatraemia

Authoring team

Specific cause should be treated. Renal function should be assessed (dialysis may be required if poor).

If not dehydrated and good renal function then decision to treat is dependent on the plasma sodium concentration. If the plasma sodium concentration is greater than 125mmol/l then treatment is rarely necessary. However, if plasma sodium is less than 125 mmol/l then the patient should be restricted to 0.5-1 litre of water/day. Should consider whether to give short term treatment with frusemide (e.g. 40-80mg/day IV or PO for two days). Occasionally, SIADH is treated by producing nephrogenic diabetes insipidus, e.g. with demeclocycline.

If the patient is dehydrated and the kidney function is good then normal saline can be administered. If an emergency, e.g. patient fitting or comatosed, then should consider administration of rapid IVI of normal saline or hypertonic 5% saline at 70mmol Na+/h. Should monitor electrolytes and possible heart failure. Consult biochemist or nephrologist concerning management.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.